Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer

PURPOSE: Neoadjuvant chemotherapy followed by radical cystectomy (RC) is a standard of care for the management of muscle-invasive bladder cancer (MIBC). Dose-dense cisplatin-based regimens have yielded favorable outcomes compared with standard-dose chemotherapy, yet the optimal neoadjuvant regimen r...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Clin Oncol
Main Authors: Iyer, Gopa, Balar, Arjun V., Milowsky, Matthew I., Bochner, Bernard H., Dalbagni, Guido, Donat, S. Machele, Herr, Harry W., Huang, William C., Taneja, Samir S., Woods, Michael, Ostrovnaya, Irina, Al-Ahmadie, Hikmat, Arcila, Maria E., Riches, Jamie C., Meier, Andreas, Bourque, Caitlin, Shady, Maha, Won, Helen, Rose, Tracy L., Kim, William Y., Kania, Brooke E., Boyd, Mariel E., Cipolla, Catharine K., Regazzi, Ashley M., Delbeau, Daniela, McCoy, Asia S., Vargas, Hebert Alberto, Berger, Michael F., Solit, David B., Rosenberg, Jonathan E., Bajorin, Dean F.
格式: Artigo
語言:Inglês
出版: American Society of Clinical Oncology 2018
主題:
ORIGINAL REPORTS
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6049398/
https://ncbi.nlm.nih.gov/pubmed/29742009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.75.0158
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍